KH

Kent Hawryluk

President & CEO

MBX Biosciences, Inc.

Indianapolis, Indiana


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
MBX Biosciences, Inc.
Industry
research
Employees
58.0
Seniority
C suite
Annual Revenue
17300000.0

Technologies

Outlook GoDaddy Hosting Adobe Marketing Cloud WordPress.org Mobile Friendly Cedexis Radar Typekit Varnish Bootstrap Framework BugHerd Greenhouse.io Vimeo reCAPTCHA Adobe Media Optimizer Google Tag Manager Google Font API

Keywords

biotechnology: pharmaceutical preparations health care biotechnology research precision therapeutics endocrine disorders metabolic disorders clinical trials peptide therapeutics canvuparatide pep candidates hypoparathyroidism treatment long-acting peptides pharmaceutical development innovation in healthcare peptide drug design pioneering therapies patient advocacy glucose management weight loss solutions hypoglycemia prevention hormone replacement therapy subcutaneous injection pharmacokinetics transformative medicine chronic disease management biopharmaceutical company clinical development best-in-class therapies precision medicine medical research regulatory affairs drug commercialization bioengineering hormone analogues healthcare solutions drug pipeline therapeutic options patient-centric approach innovative treatments drug discovery quality of life investigational new drug peptide modifications health outcomes pharmacodynamics peptide chemistry molecular biophysics bariatric surgery complications obesity treatment glp-1 agonist gip agonist patient empowerment health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans